Colorectal Cancer

The FDA has approved two treatments for Helicobacter pylori infection in adults. Both regimens contain vonoprazan, a potassium-competitive acid blocker. The announcement was the top story in gastroenterology last week.

Worldwide prevalence of sporadic colorectal cancer— long viewed as a disease of older individuals — has increased steadily among those aged younger than 50 years during the past decade, according to a review paper in The Lancet Oncology.

Women who initiated endoscopy screening before age 50 years demonstrated a significantly reduced risk for colorectal cancer than women who did not undergo endoscopy, according to study results published in JAMA Oncology.

The U.S. Multi-Society Task Force on colorectal cancer published updated guidance for the diagnosis, assessment and management of patients with gastrointestinal hamartomatous polyposis syndromes, with a focus on cancer risk.

Patients with a genetic predisposition for colorectal cancer could help define risk-adapted surveillance intervals after detection and removal of adenomas at colonoscopy, according to recent findings.

In a Healio video exclusive, Subhankar Chakraborty, MD, PhD, a gastroenterologist at The Ohio State University Wexner Medical Center, outlines a new initiative that aims to cut colorectal cancer screening disparities in half by 2023.

In partnership with the Colon Cancer Coalition, Salix Pharmaceuticals launched the Faces of Blue campaign to raise awareness about the importance of colorectal cancer screening and early detection.

More than 70% of patients with metastatic colorectal cancer bore financial hardships within the first year of diagnosis despite most having health insurance, according to study results published in Journal of the National Cancer Institute.

Cancer screening remains in need of urgent attention, and online resources may help facilities close gaps and address screenings missed in 2020, according to a prospective quality improvement study published in Cancer.

Artificial intelligence-assisted colonoscopy reduced the colorectal neoplasia miss rate by nearly twofold compared with colonoscopy alone, according to research published in Gastroenterology.